Researchers discovered how certain tumors trigger a severe immune response, causing rapid-onset memory loss and cognitive deficits, a condition known as anti-Ma2 paraneoplastic neurological syndrome. This rare syndrome, affecting less than one in 10,000 cancer patients, results from the immune system attacking brain proteins that resemble viral structures.
